ÂÜÀòÂÒÂ×

Peter Mercelis is an experienced entrepreneur and executive in the medical technology field, currently serving as Co-Founder and CEO of Replasia BV, a company focused on innovative treatments for hip dysplasia. Mercelis holds advisory and leadership roles in multiple organizations, including Onicor, Amnovis, and AdditiveLab, contributing to advancements in drug delivery, additive manufacturing, and medical devices. As a board member for Antleron and former non-executive chairman at Bond High Performance 3D Technology, Mercelis plays a significant role in the development of next-generation therapies and 3D printing technologies. A graduate of KU Leuven with a PhD in Mechanical Engineering, Mercelis has a strong foundation in healthcare innovations, previously holding a director position at 3D Systems Corporation.